LY 510929
Alternative Names: LY 929Latest Information Update: 23 Mar 2009
At a glance
- Originator Eli Lilly and Company; Ligand Pharmaceuticals
- Class Antihyperglycaemics; Phenylpropionates; Small molecules; Thiophenes
- Mechanism of Action Peroxisome proliferator-activated receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hyperlipidaemia; Metabolic disorders; Type 2 diabetes mellitus
Most Recent Events
- 23 Mar 2009 Discontinued - Phase-I for Hyperlipidaemia in USA (unspecified route)
- 23 Mar 2009 Discontinued - Phase-I for Metabolic disorders in USA (unspecified route)
- 23 Mar 2009 Discontinued - Phase-I for Type-2 diabetes mellitus in USA (unspecified route)